Access the full text.
Sign up today, get DeepDyve free for 14 days.
Gallucci (1986)
The Hancock porcine valve 15 years later: an analysis of 575 patients
S. Gabbay, U. Bortolotti, F. Wasserman, S. Factor (1984)
Haemodynamics and durability of mitral bioprostheses--an in vitro study.European heart journal, 5 Suppl D
A. Milano, U. Bortolotti, E. Talenti, C. Valfré, E. Arbustini, M. Valente, A. Mazzucco, V. Gallucci, G. Thiene (1984)
Calcific degeneration as the main cause of porcine bioprosthetic valve failure.The American journal of cardiology, 53 8
V. Gallucci, U. Bortolotti, A. Milano, C. Valfré, A. Mazzucco, G. Thiene (1984)
Isolated mitral valve replacement with the Hancock bioprosthesis: a 13-year appraisal.The Annals of thoracic surgery, 38 6
Bortolotti (1986)
Failure of porcine versus pericardial bioprostheses: the role of tissue calcificationRev Eur Technol Biomed, 8
Ionescu Mi (1986)
Long-term durability of the pericardial valve.Zeitschrift Fur Kardiologie
Gallucci (1982)
Heart valve replacement with the Hancock bioprosthesis: a 5–11 year follow-up
S. Gabbay, U. Bortolotti, F. Wasserman, S. Factor, J. Strom, R. Frater (1984)
Fatigue-induced failure of the Ionescu-Shiley pericardial xenograft in the mitral position. In vivo and in vitro correlation and a proposed classification.The Journal of thoracic and cardiovascular surgery, 87 6
G. Reul, D. Cooley, J. Duncan, O. Frazier, G. Hallman, J. Livesay, D. Ott, W. Walker (1985)
Valve failure with the Ionescu-Shiley bovine pericardial bioprosthesis: analysis of 2680 patients.Journal of vascular surgery, 2 1
U. Bortolotti, G. Thiene, A. Milano, G. Panizzon, M. Valente, V. Gallucci (1981)
Pathological study of infective endocarditis on Hancock porcine bioprostheses.The Journal of thoracic and cardiovascular surgery, 81 6
Ionescu (1982)
Clinical durability of the pericardial xenograft valve: 11 years' experience
Reul (1986)
Valve failure with the Ionescu-Shiley bovine pericardial bioprosthesis: analysis of 2680 patientsJ Vasc Surg, 2
M. Valente, U. Bortolotti, G. Thiene (1985)
Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure.The American journal of pathology, 119 1
Bortolotti (1986)
Early mechanical failure of the Hancock pericardial xenograft: a clinico-pathological study
S. Gabbay, D. McQueen, E. Yellin, R. Becker, R. Frater (1978)
In vitro hydrodynamic comparison of mitral valve prostheses at high flow rates.The Journal of thoracic and cardiovascular surgery, 76 6
S. Gabbay, R. Frater (1982)
In vitro comparison of the new generation of mitral bioprosthetic valves.Transactions - American Society for Artificial Internal Organs, 28
S. Gabbay, U. Bortolotti, F. Wasserman, N. Tindel, S. Factor, R. Frater (1984)
Long-term follow-up of the Ionescu-Shiley mitral pericardial xenograft.The Journal of thoracic and cardiovascular surgery, 88 5 Pt 1
U. Bortolotti, A. Milano, A. Mazzucco, C. Valfré, E. Talenti, F. Guerra, G. Thiene, V. Gallucci (1985)
Results of reoperation for primary tissue failure of porcine bioprostheses.The Journal of thoracic and cardiovascular surgery, 90 4
AbstractThe Hancock pericardial xenograft has been used in our Institution sinceAugust 1981 as an alternative to porcine bioprostheses. Up to July 1984, 97Hancock pericardial xenografts have been implanted in 84 patients; of 76operative survivors with a mean age of 55.2 +/- 13 years (range 13-75years), 50 had undergone aortic valve replacement, 16 mitral valvereplacement and 10 mitral-aortic valve replacement. Follow-up ranged from0.5 to 5.2 years with a cumulative duration of 239 patient/years and is 99%complete. Actuarial survival is 92% +/- 4% for patients with aortic valvereplacement and 84% +/- 10% for patients with mitral valve replacement at 5years, and 77% +/- 14% for those with mitral-aortic valve replacement at 4years. Thromboembolic episodes occurred in 2 patients (1 after aortic and 1after mitral valve replacement). The actuarial freedom from emboli is 100%for patients with mitral-aortic valve replacement at 4 years, and 96% +/-3% for patients with aortic and 93% +/- 6% for patients with mitral valvereplacement at 5 years. Reoperation was performed in 13 patients (9 aortic,2 mitral and 2 mitral-aortic valve replacements), because of endocarditisin 3 (2 aortic and 1 mitral valve replacement), paravalvular leak in 1(aortic valve replacement), and primary tissue failure in 9 (6 aortic, 1mitral and 2 mitral-aortic valve replacements). Actuarial freedom fromprimary tissue failure is 72% +/- 9% for aortic and 83% +/- 8% for mitralHancock pericardial xenografts at 5 years. Eleven xenografts explantedbecause of primary tissue failure were studied pathologically.(ABSTRACTTRUNCATED AT 250 WORDS)
European Journal of Cardio-Thoracic Surgery – Oxford University Press
Published: Nov 1, 1988
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.